Treatment of refractory status epilepticus in childhood

John M Schreiber1, William D Gaillard

  • 1Department of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA. jschreib@cnmc.org

Insights

Refractory status epilepticus (RSE) is a prolonged seizure resistant to initial treatment, posing significant risks. This review examines current RSE treatment strategies, focusing on patient selection, medication, and monitoring for improved outcomes.

Area of Science:

  • Neurology
  • Critical Care Medicine

Background:

  • Refractory status epilepticus (RSE) is a neurological emergency accounting for nearly 25% of all status epilepticus cases.
  • RSE is associated with substantial morbidity and mortality, necessitating effective treatment protocols.

Purpose of the Study:

  • To review current treatment strategies for RSE.
  • To provide guidance on patient selection, monitoring, and medication management for RSE.

Main Methods:

  • Review of current literature on RSE treatment.
  • Analysis of various therapeutic agents including nonanesthetic and anesthetic antiepileptic drugs (AEDs).
  • Focus on optimal dosing, administration, efficacy, adverse effects, and treatment duration.

Main Results:

  • Treatment approaches for RSE vary significantly across institutions.
  • Multiple classes of AEDs and other therapies are employed in RSE management.
  • Key considerations include patient selection, precise monitoring, and individualized medication strategies.

Conclusions:

  • Standardized treatment protocols for RSE are lacking.
  • Optimizing medication selection, dosing, and monitoring is crucial for managing RSE.
  • Further research may refine treatment guidelines for refractory status epilepticus.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...